Viewing StudyNCT00003091



Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00003091
Status: COMPLETED
Last Update Posted: 2011-05-12
First Post: 1999-11-01

Brief Title: High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma
Sponsor: Hoag Memorial Hospital Presbyterian
Organization: Hoag Memorial Hospital Presbyterian

Organization Data

Organization: Hoag Memorial Hospital Presbyterian
Class: OTHER
Study ID: CDR0000065795
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Hoag Memorial Hospital Presbyterian
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Robert O Dillman MD
Old Organization: Hoag Memorial Hospital Presbyterian

Collaborators

Name Class
Cancer Biotherapy Research Group OTHER